Keymed Biosciences Inc. (HKG: 2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
43.70
-1.05 (-2.35%)
Nov 12, 2024, 4:08 PM HKT

Keymed Biosciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
10,84513,58614,2679,651--
Market Cap Growth
-17.71%-4.77%47.83%---
Enterprise Value
8,88410,72510,42415,170--
Last Close Price
39.3549.1051.0034.50--
PS Ratio
117.2934.83126.1271.30--
PB Ratio
3.834.133.782.16--
P/TBV Ratio
3.304.133.782.15--
EV/Sales Ratio
101.2627.4992.15112.08--
Debt / Equity Ratio
0.280.160.040.01-1.33-2.93
Asset Turnover
0.020.090.030.05--
Inventory Turnover
0.280.660.071.02--
Quick Ratio
4.688.808.4531.554.426.99
Current Ratio
4.989.368.7231.964.757.24
Return on Equity (ROE)
-24.70%-11.31%-8.69%-305.24%--
Return on Assets (ROA)
-13.19%-7.32%-8.65%-10.09%-15.67%-
Return on Capital (ROIC)
-14.63%-8.26%-9.52%-11.15%-20.89%-
Earnings Yield
-8.55%-2.91%-2.44%-49.44%--
FCF Yield
-10.29%-5.12%-5.39%-4.91%--
Buyback Yield / Dilution
-0.22%-0.09%-62.34%-139.72%--
Total Shareholder Return
-0.22%-0.09%-62.34%-139.72%--
Source: S&P Capital IQ. Standard template. Financial Sources.